Wen-Yu Pan

1.5k total citations
27 papers, 1.3k citations indexed

About

Wen-Yu Pan is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Wen-Yu Pan has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Wen-Yu Pan's work include Cancer therapeutics and mechanisms (7 papers), Immunotherapy and Immune Responses (5 papers) and Nanoplatforms for cancer theranostics (4 papers). Wen-Yu Pan is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Immunotherapy and Immune Responses (5 papers) and Nanoplatforms for cancer theranostics (4 papers). Wen-Yu Pan collaborates with scholars based in Taiwan, United States and Czechia. Wen-Yu Pan's co-authors include Hsing‐Wen Sung, Jang‐Yang Chang, Chieh‐Cheng Huang, Ching‐Chuan Kuo, Wei-Chih Lin, Meng‐Ju Li, Chiranjeevi Korupalli, Li‐Tzong Chen, Yen Chang and Jing‐Ping Liou and has published in prestigious journals such as ACS Nano, The Journal of Immunology and Biomaterials.

In The Last Decade

Wen-Yu Pan

27 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen-Yu Pan Taiwan 21 509 403 281 270 200 27 1.3k
Houría Boulaiz Spain 28 928 1.8× 406 1.0× 194 0.7× 149 0.6× 332 1.7× 84 2.0k
René C.‐Gaudreault Canada 26 760 1.5× 217 0.5× 597 2.1× 81 0.3× 218 1.1× 79 1.8k
Emilia Licărete Romania 26 441 0.9× 574 1.4× 80 0.3× 159 0.6× 131 0.7× 55 1.6k
Manuela Banciu Romania 22 535 1.1× 338 0.8× 67 0.2× 315 1.2× 192 1.0× 52 1.5k
Edgar Pérez‐Herrero Spain 16 707 1.4× 760 1.9× 135 0.5× 130 0.5× 252 1.3× 21 1.9k
Rajiv P. Gude India 23 733 1.4× 175 0.4× 130 0.5× 190 0.7× 362 1.8× 48 1.5k
Shan‐Yu Fung Canada 23 840 1.7× 171 0.4× 226 0.8× 347 1.3× 102 0.5× 48 1.6k
Hanqing Qian China 25 689 1.4× 725 1.8× 111 0.4× 220 0.8× 254 1.3× 58 1.8k
Chaofeng Mu China 24 929 1.8× 602 1.5× 128 0.5× 249 0.9× 399 2.0× 53 2.0k
George Mattheolabakis United States 23 1.5k 2.9× 574 1.4× 131 0.5× 264 1.0× 312 1.6× 58 2.5k

Countries citing papers authored by Wen-Yu Pan

Since Specialization
Citations

This map shows the geographic impact of Wen-Yu Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen-Yu Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen-Yu Pan more than expected).

Fields of papers citing papers by Wen-Yu Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen-Yu Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen-Yu Pan. The network helps show where Wen-Yu Pan may publish in the future.

Co-authorship network of co-authors of Wen-Yu Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Wen-Yu Pan. A scholar is included among the top collaborators of Wen-Yu Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen-Yu Pan. Wen-Yu Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiang, Jen-Ron, et al.. (2025). Polyethyleneimine/fucoidan polyplexes as vaccine carriers for enhanced antigen loading and dendritic cell activation. International Journal of Biological Macromolecules. 306(Pt 1). 141336–141336. 1 indexed citations
2.
Pan, Wen-Yu, et al.. (2025). Intranasal delivery of epigallocatechin gallate-laden platelet extracellular vesicles for mitigating retinal glaucoma. Journal of Controlled Release. 381. 113596–113596. 6 indexed citations
3.
4.
5.
Pan, Wen-Yu, Kun‐Ju Lin, Chieh‐Cheng Huang, et al.. (2016). Localized sequence-specific release of a chemopreventive agent and an anticancer drug in a time-controllable manner to enhance therapeutic efficacy. Biomaterials. 101. 241–250. 20 indexed citations
6.
Korupalli, Chiranjeevi, Chieh‐Cheng Huang, Wei-Chih Lin, et al.. (2016). Acidity-triggered charge-convertible nanoparticles that can cause bacterium-specific aggregation in situ to enhance photothermal ablation of focal infection. Biomaterials. 116. 1–9. 152 indexed citations
7.
Huang, Chieh‐Cheng, Hao-Ji Wei, Kun‐Ju Lin, et al.. (2015). Multimodality noninvasive imaging for assessing therapeutic effects of exogenously transplanted cell aggregates capable of angiogenesis on acute myocardial infarction. Biomaterials. 73. 12–22. 21 indexed citations
8.
Pan, Wen-Yu, et al.. (2015). Synergistic antibacterial effects of localized heat and oxidative stress caused by hydroxyl radicals mediated by graphene/iron oxide-based nanocomposites. Nanomedicine Nanotechnology Biology and Medicine. 12(2). 431–438. 120 indexed citations
9.
10.
Liou, Jing‐Ping, Ching‐Chuan Kuo, Chi-Yen Chang, et al.. (2013). MPT0B098, a Novel Microtubule Inhibitor That Destabilizes the Hypoxia-Inducible Factor-1α mRNA through Decreasing Nuclear–Cytoplasmic Translocation of RNA-Binding Protein HuR. Molecular Cancer Therapeutics. 12(7). 1202–1212. 32 indexed citations
11.
Chen, Chih‐Cheng, Ko‐Jiunn Liu, Chi‐Ying F. Huang, et al.. (2013). Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: The role of IL-6 signaling and Nrf2/AKR1C axis identification. Biochemical Pharmacology. 86(7). 872–887. 49 indexed citations
12.
Pan, Wen-Yu, et al.. (2012). Cancer Immunotherapy Using a Membrane-bound Interleukin-12 With B7-1 Transmembrane and Cytoplasmic Domains. Molecular Therapy. 20(5). 927–937. 31 indexed citations
13.
Yang, Yung‐Ning, Kai-Ming Chou, Wen-Yu Pan, et al.. (2011). Enhancement of non-homologous end joining DNA repair capacity confers cancer cells resistance to the novel selenophene compound, D-501036. Cancer Letters. 309(1). 110–118. 8 indexed citations
14.
Hsieh, Cheng‐Chih, Yueh‐Hsiung Kuo, Ching‐Chuan Kuo, et al.. (2009). Chamaecypanone C, a novel skeleton microtubule inhibitor, with anticancer activity by trigger caspase 8-Fas/FasL dependent apoptotic pathway in human cancer cells. Biochemical Pharmacology. 79(9). 1261–1271. 23 indexed citations
15.
Chang, Jang‐Yang, Yi‐Wen Lin, Wen-Yu Pan, et al.. (2005). Synthesis and antitumor activity of 5-(9-acridinylamino)anisidine derivatives. Bioorganic & Medicinal Chemistry. 13(23). 6513–6520. 30 indexed citations
16.
Chang, Chi-I, Jang‐Yang Chang, Ching‐Chuan Kuo, Wen-Yu Pan, & Yueh‐Hsiung Kuo. (2005). Four New 6-Nor-5(6→7)abeo-abietane Type Diterpenes and Antitumoral Cytotoxic Diterpene Constituents from the Bark ofTaiwania cryptomerioides. Planta Medica. 71(1). 72–76. 73 indexed citations
17.
Juang, Shin‐Hun, Wen-Yu Pan, Ching‐Chuan Kuo, et al.. (2004). A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells. Biochemical Pharmacology. 68(2). 293–303. 14 indexed citations
18.
Lee, Shan‐Chih, Wen-Yu Pan, Chao‐Wen Cheng, et al.. (2003). Antitumor and Antimetastatic Activity of IL-23. The Journal of Immunology. 171(2). 600–607. 140 indexed citations
19.
Chang, Jang‐Yang, Wen-Yu Pan, Ting‐Chao Chou, et al.. (2003). New analogues of AHMA as potential antitumor agents: synthesis and biological activity. Bioorganic & Medicinal Chemistry. 11(23). 4959–4969. 23 indexed citations
20.
Chang, Jang‐Yang, et al.. (2002). Antitumor AHMA Linked to DNA Minor Groove Binding Agents:  Synthesis and Biological Evaluation. Journal of Medicinal Chemistry. 45(20). 4485–4493. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Houría Boulaiz Breakdown of academic impact, for papers by René C.‐Gaudreault Breakdown of academic impact, for papers by Emilia Licărete Breakdown of academic impact, for papers by Manuela Banciu Breakdown of academic impact, for papers by Edgar Pérez‐Herrero Breakdown of academic impact, for papers by Rajiv P. Gude Breakdown of academic impact, for papers by Shan‐Yu Fung Breakdown of academic impact, for papers by Hanqing Qian Breakdown of academic impact, for papers by Chaofeng Mu Breakdown of academic impact, for papers by George Mattheolabakis
Rankless by CCL
2026